Concepedia

Compound Prioritization

Compound Prioritization is a computational strategy within drug discovery that ranks candidate compounds based on predicted biological activity, physicochemical properties, or therapeutic potential to identify the most promising molecules for further experimental evaluation.

141

Publications

8.7K

Citations

766

Authors

278

Institutions

Publications per year

2017–2026

40

Parents

Publications

141

Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases

Ruth Brenk, Alessandro Schipani, Daniel James et al. · ChemMedChem · 2007 · 694 citations · Full text

, , +16

Use of Structure−Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection

Robert D. Brown, Yvonne C. Martin · Journal of Chemical Information and Computer Sciences · 1996 · 633 citations

, , +16

Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery

Travis T. Wager, Xinjun Hou, Patrick R. Verhoest et al. · ACS Chemical Neuroscience · 2016 · 605 citations · Full text

, , +11

FAF-Drugs3: a web server for compound property calculation and chemical library design

David Lagorce, Olivier Spérandio, Jonathan B. Baell et al. · Nucleic Acids Research · 2015 · 277 citations · Full text

, , +15

Overview on the Rule of Five

Michael P. Pollastri · Current Protocols in Pharmacology · 2010 · 237 citations

, , +16

1–5 of 141

Authors

766

  1. JB
    Jürgen Bajorath

    University of Bonn, Germany

    12 publications · 364 citations

    12

    h-index

  2. YH
    Ye Hu

    University of Bonn, Germany

    5 publications · 168 citations

    5

    h-index

  3. GE
    Gene E. Ananiev

    University of Wisconsin–Madison, United States

    3 publications · 103 citations

    3

    h-index

  4. AG
    Anthony Gitter

    University of Wisconsin–Madison, United States

    3 publications · 103 citations

    3

    h-index

  5. FM
    F. Michael Hoffmann

    University of Wisconsin–Madison, United States

    3 publications · 103 citations

    3

    h-index

1–5 of 766

Institutions

278

  1. University of Bonn

    Bonn, Germany

    11 h-index

    29 publications

    934 citations

  2. Novartis (Switzerland)

    Basel, Switzerland

    7 h-index

    25 publications

    901 citations

  3. AstraZeneca (Sweden)

    Södertälje, Sweden

    5 h-index

    12 publications

    256 citations

  4. Pfizer (United States)

    New York, United States

    5 h-index

    13 publications

    2.9K citations

  5. AstraZeneca (United Kingdom)

    Cambridge, United Kingdom

    4 h-index

    24 publications

    578 citations

  6. Novartis Institutes for BioMedical Research

    Basel, Switzerland

    4 h-index

    9 publications

    360 citations

  7. Abbott Fund

    Chicago, United States

    4 h-index

    13 publications

    1.6K citations

  8. University of California, San Francisco

    San Francisco, United States

    3 h-index

    8 publications

    204 citations

1–8 of 278

Venues

  1. Journal of Chemical Information and Modeling

    JCIM · 18 publications · 630 citations

    15

    h-index

  2. 8

    h-index

  3. Journal of Medicinal Chemistry

    8 publications · 258 citations

    7

    h-index

  4. Drug Discovery Today

    5 publications · 196 citations

    5

    h-index

  5. SLAS DISCOVERY

    4 publications · 275 citations

    4

    h-index

1–5